:format(webp)/cdn.mskdoctors.com/storage/2026/9/F3M5ydLUMmZsFc0ECMdmh0YWdgHcQcDh.jpg)
ChondroFiller Injection for Post-Traumatic Knee Cartilage DamageCartilage damage from knee fractures cannot heal spontaneously and carries elevated osteoarthritis risk; ChondroFiller, an injectable collagen scaffold, recruits the patient's own stem cells to repair these focal defects.Cartilage damage from knee fractures cannot heal spontaneously and carries elevated osteoarthritis risk; ChondroFiller, an injectable collagen scaffold, recruits the patient's own stem cells to repair these focal defects.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/SBmsVEyBqtof0WMPbvBeYdD1nSFHZHd2.jpg)
Unloader knee brace or surgery for cartilage damageUnloader braces open the joint 0.3 mm, modulating cartilage chemistry without rebuilding damage; high tibial osteotomy substantially outperforms bracing for pain relief in younger patients.Unloader braces open the joint 0.3 mm, modulating cartilage chemistry without rebuilding damage; high tibial osteotomy substantially outperforms bracing for pain relief in younger patients.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/Mf2xfpLpk5v5iyif5YXaeLW842LflGA2.jpg)
Knee cartilage damage symptoms and who to seeArticular cartilage lacks a blood supply and cannot repair itself; untreated defects larger than 1 cm risk progressive worsening and osteoarthritis.Articular cartilage lacks a blood supply and cannot repair itself; untreated defects larger than 1 cm risk progressive worsening and osteoarthritis.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/KrFVoOQZ12jhh6MLUrwKAQtNJok3RQHr.jpg)
Knee Cartilage Repair and PreservationArticular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.Articular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/PkyQqvkgI6yAHN0E9iIKdMMEOp69yzRa.jpg)
How defect size determines OATS or OCAAutograft supply draws the line: defects below 2–4 cm² use OATS, harvesting bone and cartilage from the patient's own knee; larger lesions require OCA, using cadaveric tissue, because autograft volume runs out before expansive defects are adequately covered.Autograft supply draws the line: defects below 2–4 cm² use OATS, harvesting bone and cartilage from the patient's own knee; larger lesions require OCA, using cadaveric tissue, because autograft volume runs out before expansive defects are adequately covered.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/WyTUgPyuRTUUHCpsWkxQLHIH1zV03yj2.jpg)
Can ChondroFiller delay joint replacement?An injectable collagen scaffold called ChondroFiller recruits the patient's own repair cells to regenerate cartilage in 30–45 minutes. Clinical trials show IKDC score improvements averaging 32.4 points — nearly double the threshold for clinically significant change — when administered in early focal cartilage damage where joint space remains.An injectable collagen scaffold called ChondroFiller recruits the patient's own repair cells to regenerate cartilage in 30–45 minutes. Clinical trials show IKDC score improvements averaging 32.4 points — nearly double the threshold for clinically significant change — when administered in early focal cartilage damage where joint space remains.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/2of3MbpwJvcJrDYn03x9VVz3ZGqDUeFf.jpg)
ChondroFiller vs hyaluronic acid for cartilage repairChondroFiller repairs focal cartilage lesions by recruiting the patient's own cells; hyaluronic acid eases broad osteoarthritis by restoring synovial fluid. These injections treat fundamentally different conditions, and selecting the wrong one offers little clinical value.ChondroFiller repairs focal cartilage lesions by recruiting the patient's own cells; hyaluronic acid eases broad osteoarthritis by restoring synovial fluid. These injections treat fundamentally different conditions, and selecting the wrong one offers little clinical value.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/766rT75vrzgAcHwc9vxAXYr5JrU3PaGe.jpg)
ChondroFiller injection versus knee replacement for focal defectsChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.ChondroFiller, a gelling collagen scaffold that recruits the patient's own cells to repair cartilage, suits isolated focal defects; knee replacement addresses widespread multi-compartment osteoarthritis.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/JRFtBp0mcZmXZbOaQOz1rXHk9oX5RoWx.jpg)
Knee cartilage damage left untreated and when repair helpsCartilage lacks blood vessels, nerve fibres, and lymph channels, so repair cells cannot reach injuries and pain does not warn of damage, allowing lesions to expand silently until they become clinically serious.Cartilage lacks blood vessels, nerve fibres, and lymph channels, so repair cells cannot reach injuries and pain does not warn of damage, allowing lesions to expand silently until they become clinically serious.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/Glw9JbiPP4VAFQxjx5hgGynC18Pe38KX.jpg)
Who qualifies for ChondroFiller injectionChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.ChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.
:format(webp)/cdn.mskdoctors.com/storage/2026/8/rjdUoSXZw7DBQPxbfDpZXz3tnkbbwYXu.jpg)
Who qualifies for MACI knee surgery?Patients aged 18–55 with deep focal cartilage damage (Grade III-IV, >2 cm²) qualify for MACI if their knees are structurally sound—stable ligaments, correct alignment, no generalised osteoarthritis—and conservative treatment has failed. The procedure is two-stage, with extended rehabilitation required.Patients aged 18–55 with deep focal cartilage damage (Grade III-IV, >2 cm²) qualify for MACI if their knees are structurally sound—stable ligaments, correct alignment, no generalised osteoarthritis—and conservative treatment has failed. The procedure is two-stage, with extended rehabilitation required.
:format(webp)/cdn.mskdoctors.com/storage/2026/7/8ilKw2XCH5pB5TWOt6kewJNVnwz4zE0V.jpg)
What the ChondroFiller evidence actually showsChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.ChondroFiller's reoperation rate of 3–8% substantially outperforms microfracture (41%) and ACI/MACI (37%), reflecting its mechanism: the scaffold supports hyaline-like cartilage repair rather than the fibrocartilage scar tissue that other approaches produce.
